Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Yimeng Fang, Ph.D.

Concepts (13)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Yimeng Fang's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Yimeng Fang has written about over time.
Cell Cycle Proteins, 1 publications between 2024 and 2024, average publication date July 2024. DNA Polymerase I, 1 publications between 2024 and 2024, average publication date July 2024. DNA Replication, 1 publications between 2024 and 2024, average publication date July 2024. DNA-Binding Proteins, 1 publications between 2024 and 2024, average publication date July 2024. Epigenesis, Genetic, 1 publications between 2024 and 2024, average publication date July 2024. Heterochromatin, 1 publications between 2024 and 2024, average publication date July 2024. High Mobility Group Proteins, 1 publications between 2024 and 2024, average publication date July 2024. Histone Chaperones, 1 publications between 2024 and 2024, average publication date July 2024. Histones, 1 publications between 2024 and 2024, average publication date July 2024. Molecular Chaperones, 1 publications between 2024 and 2024, average publication date July 2024. Saccharomyces cerevisiae, 1 publications between 2024 and 2024, average publication date July 2024. Saccharomyces cerevisiae Proteins, 1 publications between 2024 and 2024, average publication date July 2024. Transcriptional Elongation Factors, 1 publications between 2024 and 2024, average publication date July 2024.

To see the data from this visualization as text, click here.
Fang's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (13)
Explore
_
Co-Authors (4)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.